Edward M. Fitzgerald's most recent trade in Parabilis Medicines Inc. was a trade of 20,215 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Parabilis Medicines Inc | Edward M. Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 20,215 | 20,215 | - | - | Stock Option (Right to Buy) | |
| Parabilis Medicines Inc | Edward M. Fitzgerald | Director | 09 Jun 2026 | 8,111 | 0 | - | - | Series F Preferred Stock | ||
| Parabilis Medicines Inc | Edward M. Fitzgerald | Director | 09 Jun 2026 | 5,539 | 5,539 | - | - | Common Stock | ||
| Parabilis Medicines Inc | Edward M. Fitzgerald | Director | 09 Jun 2026 | 5,332 | 0 | - | - | Series B Preferred Stock | ||
| Parabilis Medicines Inc | Edward M. Fitzgerald | Director | 09 Jun 2026 | 5,271 | 14,688 | - | - | Common Stock | ||
| Parabilis Medicines Inc | Edward M. Fitzgerald | Director | 09 Jun 2026 | 3,878 | 9,417 | - | - | Common Stock | ||
| Parabilis Medicines Inc | Edward M. Fitzgerald | Director | 09 Jun 2026 | 3,666 | 0 | - | - | Series C Preferred Stock |